Skip to main content

6th Global Forum on TB Vaccines - Registration Open

Registration for the 6th Global Forum on TB Vaccines is now open! Join researchers, product developers, advocates, community representatives, and others interested and engaged in TB vaccine R&D from around the world to review the state of the field and discuss the path forward for this important research.

The 6th Global Forum will be a hybrid event, with options for in-person and virtual participation. Discounted registration fees are available for students and participants from lower- and middle-income countries.

Register now at https://toulouse.tbvaccinesforum.org/register/

 

__________________________________________________________________________

Toulouse has been selected to host the 6th Global Forum on Tuberculosis Vaccines from february 22 to 24, 2022, following the French application carried by our laboratory and very strongly supported by the CNRS (French National Center for Scientific Research).

 

In line with with France's policy for a global health, this Forum will take place under the High Patronage of the President of the Republic and the patronage of the Ministry for Solidarity and Health, and benefits from the support of the Ministry for Higher Education, Research and Innovation. Toulouse's application for France has received the support of a large number of partners, including local institutions (Occitania Region, Department of Haute-Garonne, Toulouse-M├ętropole, Toulouse Federal University, Toulouse University Hospital), research institutions and partnerships (CNRS, Inserm, Institut Pasteur, AVIESAN, ANRS, EDCTP), learning societies, foundations and private entities.

 

The Forum represents a unique opportunity for France to inform an international audience about the progress of research and its contributions in the fight against tuberculosis, and more generally infectious diseases and antibiotic resistance, at a time when Europe is seeing this ancient disease re-emerge and, more generally, the threat of infectious diseases increasing alarmingly.